Who to call at ProMIS Neurosciences Inc., and when
Fundz watches for the moments ProMIS Neurosciences Inc. starts buying, and tells you who to reach.
- An alert the day ProMIS Neurosciences Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ProMIS Neurosciences Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ProMIS Neurosciences Inc.. With Fundz connected, it knows.
ProMIS Neurosciences Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.promisneurosciences.comAI Executive Summary
AI-powered analysis of 8-K filing content
ProMIS Neurosciences appointed Slanix Paul Alex, Pharm.D., President and Portfolio Manager of Ally Bridge Group's Public Equity strategy, as an independent director effective October 22, 2025. The addition brings a life sciences investor with public equity experience to the board, and his compensation includes a 40,000-share initial option grant and a $40,000 annual fee.
Key Takeaways
Dr. Alex was appointed to the board on October 22, 2025, on the recommendation of the Corporate Governance and Nominating Committee, and will serve until the 2026 annual meeting of stockholders.
The board determined that Dr. Alex is independent under Nasdaq listing standards, and the composition of the Compensation, Nominating and Audit Committees is unchanged.
3 more takeaways
Related Filings (5)
5 more filings from ProMIS Neurosciences Inc. in the last 90 days
Filing Overview
What This Means
ProMIS Neurosciences Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.